Patent · US Active

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

US11708354B2 · kind B2 · utility

1Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2020
Grant dateJul 25, 2023
Priority date—
Expiry dateSep 25, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds which are selective allosteric inhibitors of T790M and C797S containing EGFR mutants, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.